During the past decade, Into Research conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 7 clinical trials were completed, i.e. on average, 77.8% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 7 clinical trials were completed. i.e. 175% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Into Research" #1 sponsor was "Boehringer Ingelheim" with 2 trials, followed by "Janssen Research & Development, LLC" with 2 trials sponsored, "Pfizer" with 2 trials sponsored, "Shire" with 2 trials sponsored and "FibroGen" with 2 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Into Research" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Into Research" are "Influenza A" (2 trials), "Adenoviral Conjunctivitis" (1 trials), "Bacterial Conjunctivitis" (1 trials), "COVID-19" (1 trials) and "Covid19" (1 trials). Many other conditions were trialed in "Into Research" in a lesser frequency.

Most popular intervention types in "Into Research" are "Drug" (9 trials), "Other" (4 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "PVP-I 0.6%" (2 trials), "Pimodivir 600 mg" (2 trials), "SHP640" (2 trials) and "SOC Treatment" (2 trials). Other intervention names were less common.

The vast majority of trials in "Into Research" are 11 trials for "All" genders.

Currently, there are NaN active trials in "Into Research". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Into Research, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Into Research, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".